Millions of Americans take fish oil supplements hoping to keep their brains sharp as they age. But new evidence suggests those capsules may not deliver the cognitive boost many expect. While the findings may be disappointing, they highlight why clinical trials are so critical — they help determine which treatments really work before people spend time and money on them.
A two-year clinical trial followed 365 adults between the ages of 55 and 80 who were at increased risk for Alzheimer’s disease. Participants received either a daily high-dose omega-3 supplement or a placebo.
Researchers first wanted to know whether the key omega-3 nutrient, DHA, was actually reaching the brain. So, they measured DHA levels in the surrounding fluid and found an increase of about 17 percent after six months of treatment. But that didn’t translate into better outcomes, according to the results.
Memory tests and brain scans showed no advantage for those taking fish oil supplements.
Participants who received DHA saw no improvement in memory or cognitive function, and the supplements did not slow shrinkage in brain regions linked to Alzheimer’s disease, according to the results.
Researchers say the findings suggest fish oil supplements alone are unlikely to prevent the most common form of dementia.
The lead investigator says, “Staying healthy throughout life remains the most powerful tool we have for reducing Alzheimer’s risk, including regular exercise, quality sleep and a balanced diet.”
RELATED: Alzheimer’s Disease Clinical Trials: What You Need to Know
Many supplements become popular before there’s strong scientific evidence to support their true effectiveness. Clinical trials can help researchers determine whether a treatment truly works, how well it works, and who may benefit from it. While it may be disappointing when a study finds that a treatment isn’t effective, those results are just as valuable as positive findings. They help healthcare providers make evidence-based recommendations and allow researchers to focus on more promising approaches for preventing and treating disease.
According to research, Black Americans are about twice as likely to develop Alzheimer’s or other forms of dementia, making early detection, prevention, and access to quality care especially important. Although researchers haven’t yet identified a single cause of this disparity, it’s likely a combination of genetic factors, higher rates of chronic conditions such as high blood pressure and diabetes, social and economic barriers to healthcare, and a long history of medical distrust rooted in systemic inequities.
Increasing participation by Black Americans in Alzheimer’s clinical trials can help researchers better understand how the disease affects diverse populations and whether new treatments are safe and effective across different communities. More representative research has the potential to improve care and lead to better health outcomes for everyone.
While this study suggests fish oil supplements may not prevent Alzheimer’s disease, other steps may help support brain health. Managing conditions — such as high blood pressure, diabetes, and high cholesterol — can lower the risk of cognitive decline.
Other practical approaches can include:
Although no single lifestyle change or supplement can guarantee prevention, adopting healthy habits may reduce your overall risk and support healthy aging.
RELATED: Why Dementia Screening Could Be Important for Black Families
Every Alzheimer’s clinical trial — whether it finds a treatment works or doesn’t — helps move research forward. Researchers rely on volunteers to better understand how to prevent, detect, and treat Alzheimer’s disease. Unfortunately, Black Americans have historically been underrepresented in clinical research despite facing a higher risk of developing Alzheimer’s disease. Greater participation in clinical trials can help researchers learn whether new treatments are safe and effective for people of diverse backgrounds, ultimately leading to more equitable care.
If you’re interested in contributing to the future of Alzheimer’s research, talk with your healthcare provider or visit BlackDoctor’s Clinical Trials Resource Center to learn about studies that may be enrolling participants.
The study’s findings don’t mean that brain health is hopeless. Rather, it shows why well-designed clinical trials are essential for discovering what does — and doesn’t — work in managing medical conditions. Every clinical trial brings researchers closer to finding better ways to prevent and treat Alzheimer’s disease.
Source: eBioMedicine
Author Affiliations: Keck Medicine of USC
By subscribing, you consent to receive emails from BlackDoctor.com. You may unsubscribe at any time. Privacy Policy & Terms of Service.
